BVTK yields 20000000.00% · PFE yields 6.20%● Live data
📍 BVTK pulled ahead of the other in Year 1
Combined, BVTK + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BVTK + PFE for your $10,000?
Bravatek Solutions, Inc. markets and distributes proprietary and allied security, defense, and information security software, hardware, and services in the United States and internationally. Its products include software, hardware, and services, as well as email security, user authentication, telecommunications, and cyber breach protection. These assist corporate entities, governments, and individuals in protecting their organizations and/or critical infrastructure against both physical and cyberattacks. The company's products include Ecrypt One, an email server with integrated security technology used to protect email and attachments in transit and at rest. It also offers telecommunication services, including cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G/5G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. The company has strategic alliances with Center for Threat Intelligence, LLC; OrangeHook, Inc.; KP Consulting; AG Capital Management, LLP; Optimized Fuel Technologies; MC Smart Controls; and RMA Armament, Inc. The company was formerly known as Ecrypt Technologies, Inc. and changed its name to Bravatek Solutions, Inc. in October 2015. Bravatek Solutions, Inc. was founded in 2007 and is based in Austin, Texas.
Full BVTK Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.